Cresset Asset Management, LLC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1761013
Chicago, IL
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,596,549
+$249,461 QoQ
Shares Held
383,786
0.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 292 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. IOVA ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
736,708 | $52,048,420 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
260,937 | $20,423,538 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,926 | $3,937,081 | |
| 4 | EXEL |
Exelixis, Inc.
|
70,918 | $3,858,648 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
102,479 | $3,731,260 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
35,433 | $2,012,948 | |
| 7 | MRNA |
Moderna, Inc.
|
28,359 | $1,985,980 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
11,629 | $1,777,143 |
All Filings in IOVA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,596,549 | 383,786 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,347,088 | 383,786 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,249,755 | 457,786 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $413,354 | 190,486 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $327,269 | 190,273 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $260,649 | 78,273 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $579,434 | 78,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $758,796 | 80,809 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $641,142 | 79,943 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,052,605 | 71,026 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $623,896 | 76,740 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $207,334 | 45,568 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $227,335 | 32,292 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $189,410 | 31,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $198,090 | 31,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $431,100 | 45,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $265,313 | 24,032 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $479,420 | 28,794 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $370,097 | 19,387 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $465,876 | 18,892 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $600,177 | 23,066 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $333,538 | 10,535 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||